Gray, Marcus A <br/><br/>
Anti-TNFα therapy in IBD alters brain activity reflecting visceral sensory function and cognitive-affective biases.  [electronic resource] 

 -  PloS one  2018 
 - e0193542 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0193542  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab--therapeutic use<br/>Adolescent<br/>Adult<br/>Affect--drug effects<br/>Anti-Inflammatory Agents--therapeutic use<br/>Brain--drug effects<br/>Brain Mapping<br/>Cognition--drug effects<br/>Crohn Disease--drug therapy<br/>Diagnostic Self Evaluation<br/>Female<br/>Gastrointestinal Agents--therapeutic use<br/>Humans<br/>Infliximab--therapeutic use<br/>Magnetic Resonance Imaging<br/>Male<br/>Neuropsychological Tests<br/>Random Allocation<br/>Satiation--drug effects<br/>Tumor Necrosis Factor-alpha--immunology<br/>Visceral Afferents--drug effects<br/>Young Adult